Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Cash flows from operating activities
Net income (loss)	$ 215,322	$ (864,867)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	813,234	1,124,038
Interest from amortization of debt costs	3,882	3,298
Warrants issued to consultant		7,500
Loss on disposal of property and equipment	2,273
Stock based compensation	268,307	272,044
Change in provision for doubtful accounts receivable	2,403	10,969
Change in fair value of warrant liability	14,725	(103,364)
Deferred rent	(125,510)	(118,536)
Changes in operating assets and liabilities:
Trade accounts receivables	3,769	(311,004)
Other receivables	(312,530)	(10,057)
Inventories	(257,297)	109,253
Prepaid expenses and other assets	46,473	82,671
Accounts payable and accrued liabilities	(83,111)	166,039
Deferred revenue	(35,784)	37,750
Net cash provided by operating activities	556,156	405,734
Cash flows from investing activities
Purchase of property and equipment	(1,097,470)	(628,593)
Cash flows from financing activities
Proceeds from exercise of stock options	2,612
Proceeds from sale of common stock, net of costs		1,596,786
Proceeds from sale of common stock from employee stock purchase plan	8,981	13,595
Costs associated with conversion of debentures	(40,028)
Repayments of debentures	(180,000)
Payments on capital lease obligation	(3,601)
Net cash provided by (used in) financing activities	(212,036)	1,610,381
Effect of exchange rate on cash and cash equivalents	(35,522)	37,665
Increase (decrease) in cash and cash equivalents	(788,872)	1,425,187
Cash and cash equivalents, beginning of period	2,354,087	928,900
Cash and cash equivalents, end of period	1,565,215	2,354,087
Supplemental disclosure of cash flow information:
Interest paid in cash	1,874	1,670
Income taxes paid	2,350	4,174
Supplemental disclosure of non-cash investing & financing activities:
Prepaid interest on convertible debentures through the issuance of common stock	87,000	87,000
Issuance of common stock through the conversion of 8% convertible debentures	907,500
Fair value of warrants issued to consultant	$ 13,000	$ 15,000